MIJ821 (onfasprodil) in healthy volunteers: First‐in‐human, randomized, placebo‐controlled study (single ascending dose and repeated intravenous dose)
Abstract This single‐center study administered MIJ821 (onfasprodil) as an intravenous infusion to healthy volunteers and included two parts: a single ascending dose study (Part 1) and a repeated intravenous dose study (Part 2). Primary objective was to evaluate the safety and tolerability of single...
Saved in:
Main Authors: | Baltazar Gomez‐Mancilla (Author), Jeffrey A. Levy (Author), Subramanian Ganesan (Author), Thomas Faller (Author), Gil Issachar (Author), Ziv Peremen (Author), Offir Laufer (Author), Revital Shani‐Hershkovich (Author), Kostas Biliouris (Author), Ela Walker (Author), Mark P. Healy (Author), Oleksandr Sverdlov (Author), Sachin Desai (Author), S. Nassir Ghaemi (Author), Jang‐Ho Cha (Author), Y. Gopi Shanker (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Scientific American Supplement, No. 821, September 26, 1891
by: Various -
Favorable subset of acute myeloid leukemia with translocation 8;21: An elusive experience
by: Nusrat Bashir Khan, et al.
Published: (2015) -
Favorable subset of acute myeloid leukemia with translocation 8;21: An elusive experience
by: Nusrat Bashir Khan, et al.
Published: (2015) -
A safe optically guided entry technique using Endopath Xcel Trocars in laparoscopic surgery: A personal series of 821 patients
by: Wu Shun Felix Wong
Published: (2013) -
RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification
by: Ran Li, et al.
Published: (2023)